New CE4 Plus V3 with Replaceable Atomizer Head Now Available at EZ Smoke.ie

EZ Smoke.ie are happy to announce that we have today taken stock of new CE4 Plus V3 with Replaceable Atomizer Head. Also know as Vision Ego, Stardust, these new V3 Clearomizers are a more cost effective solution for those who love the simplicity and performance of the CE4 Plus. When performance drops simply replace atomizer head rather than whole assembly.

New CE4 Plus V3 come in a choice of colours, Clear or Purple, and in 2.4 or 2.8 ohms.

Additionally EZ Smoke.ie now also supply Replacement CE4 Atomizer Heads (short wicks) in packs of 5, in 2.4 or 2.8 ohms, with long wicked versions due in soon.

Product Links:
CE4 Plus V3 – Clear, Long Wick 2.4ohms
CE4 Plus V3 – Purple, Long Wick 2.8ohms
CE4 Plus Replaceable Atomizer (Short Wick)

 

European Society of Cardiology – Electronic cigarettes do not damage the heart

Electronic cigarettes have no acute adverse effects on cardiac function, according to research presented today at an ESC Congress 2012 press conference by Dr Konstantinos Farsalinos from Greece.

Abstract
Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, with several millions of people already using them worldwide.

Electronic cigarettes simulate the effect of smoking by producing an inhaled vapor. The device consists of a battery, a cartridge containing liquid and a heating element which gets warm and evaporates the liquid. Laboratory analyses of the liquids show that they are less toxic than regular cigarettes. Most studies have found no nitrosamines, but even in studies where nitrosamines were found, the levels detected were 500-1400 times less than the amount present in one tobacco cigarette. This means that electronic cigarettes must be used daily for 4-12 months to get the amount of nitrosamines present in a single tobacco cigarette.

Since heart disease is the main cause of morbidity and mortality in smokers, with 40% of deaths in smokers due to coronary artery disease alone, the research team decided to perform the first clinical study of the acute effects of electronic cigarettes on cardiac function.

They decided to compare their results with the acute effects of regular cigarettes on cardiac function since electronic cigarettes are marketed to smokers only, as an alternative habit.

Previous studies from the research group and several others have shown that acute smoking inhalation produces significant defects in myocardial function. This indicates that subclinical dysfunction is already present in apparently healthy asymptomatic young people who smoke tobacco cigarettes. The goal was to evaluate whether these signs of preclinical disease appear in a similar population after using electronic cigarettes.

The researchers measured myocardial function in 20 healthy young daily smokers aged 25-45 years before and after smoking one tobacco cigarette and 22 daily electronic cigarette users of similar age before and after using the device for 7 minutes.

Experienced users of electronic cigarettes were studied because they use the device more intensively than first-time users. Although both groups were of equal age, users of electronic cigarettes had a 44% higher lifetime tobacco smoking exposure compared to current smokers.

For the electronic cigarettes, a commercially available liquid with a nicotine concentration of 11mg/ml was used (NOBACCO USA Mix). This was tested by an independent toxicology laboratory and found to contain no nitrosamines or polycyclic aromatic hydrocarbons.

Myocardial function was examined using cardiac ultrasound (echocardiography) and hemodynamic measurements (blood pressure and heart rate).

The researchers found that smoking one tobacco cigarette led to significant acute myocardial dysfunction but electronic cigarettes had no acute adverse effects on cardiac function. Smoking a tobacco cigarette had important hemodynamic consequences, with significant increases in systolic and diastolic blood pressure and in heart rate. In contrast, electronic cigarettes produced only a slight elevation in diastolic blood pressure. Dr Farsalinos said: “This is an indication that although nicotine was present in the liquid used (11mg/ml), it is absorbed at a lower rate compared to regular cigarette smoking.”

The echocardiography examination focused on the function of the left ventricle, the part of the heart that receives oxygenated blood from the lungs (filling or diastolic phase) and then delivers the blood to the whole body (pumping or systolic phase). The investigators found significant defects in the diastolic phase of left ventricular function after smoking one cigarette, with four echocardiographic parameters indicating worsening function. In contrast, none of the echocardiographic parameters showed any significant worsening in subjects after using the electronic cigarette. “Diastolic dysfunction is very important because it is usually the first defect that is detected before any clinically-evident cardiac disease develops,” said Dr Farsalinos.

He added: “It is too early to say whether the electronic cigarette is a revolution in tobacco harm reduction but the potential is there. It is the only available product that deals with both the chemical (nicotine delivery) and psychological (inhaling and exhaling ‘smoke’, holding it, etc) addiction to smoking, laboratory analyses indicate that it is significantly less toxic and our study has shown no significant defects in cardiac function after acute use.”

Dr Farsalinos continued: “More clinical studies need to be done before suggesting that this is a revolutionary product. However, considering the extreme hazards associated with cigarette smoking, currently available data suggest that electronic cigarettes are far less harmful and substituting tobacco with electronic cigarettes may be beneficial to health.”

Dr Farsalinos will also present his results during an ESC Congress 2012 scientific session tomorrow.

Contributors:
Konstantinos Farsalinos, MD1, Dimitris Tsiapras, MD1, Stamatis Kyrzopoulos, MD1, and Vassilis Voudris, MD1

1 Onassis Cardiac Surgery Center, Athens, Greece

Authors: Dr Konstantinos Farsalinos (Greece), Onassis Cardiac Surgery Center

Greek study finds e-cigarettes no threat to heart

(Reuters) – Electronic cigarettes, an increasingly popular option among smokers trying to quit, do not appear to pose a threat to the heart, according to results of a clinical study presented on Saturday.

from http://www.reuters.com/article/2012/08/25/us-heart-ecigarettes-idUSBRE87O05Y20120825

Greek researchers said e-cigarettes – battery-powered metal tubes that transform liquid laced with nicotine into vapour – had no adverse effects on cardiac function in their small trial.

“Electronic cigarettes are not a healthy habit but they are a safer alternative to tobacco cigarettes,” Dr Konstantinos Farsalinos from the Onassis Cardiac Surgery Center in Athens told the annual meeting of the European Society of Cardiology.

“Considering the extreme hazards associated with cigarette smoking, currently available data suggest that electronic cigarettes are far less harmful and substituting tobacco with electronic cigarettes may be beneficial to health.”

Farsalinos and his team examined the heart function of 20 young smokers before and after smoking one tobacco cigarette against that of 22 e-cigarette users before and after using the device for seven minutes.

While the tobacco smokers suffered significant heart dysfunction, including raised blood pressure and heart rate, those using e-cigarettes had only a slight elevation in pressure.

The Greek clinical study was the first in the world to look at the cardiac effects of e-cigarettes. Another small study, also in Greece, reported earlier this year the devices had little impact on lung function.

Farsalinos acknowledged bigger studies were still needed to examine the possible long-term effects of e-cigarettes, while other doctors attending the medical meeting in Munich were cautious about giving them a clean bill of health just yet.

“Obviously, the e-cigarette has the advantage of not having the thousands of other chemicals, besides nicotine, that a real cigarette has,” said Dr Russell Luepker of the University of Minnesota.

“I don’t think it’s conclusive but there’s no doubt if you expose someone to fewer bioactive chemical compounds there is going to be less effect.”

E-cigarettes were first made in China in 2003 but are now sold around the world and used by millions of people.

(Reporting by Ben Hirschler; Editing by Andrew Heavens)(Reuters) – Electronic cigarettes, an increasingly popular option among smokers trying to quit, do not appear to pose a threat to the heart, according to results of a clinical study presented on Saturday.

Greek researchers said e-cigarettes – battery-powered metal tubes that transform liquid laced with nicotine into vapour – had no adverse effects on cardiac function in their small trial.

“Electronic cigarettes are not a healthy habit but they are a safer alternative to tobacco cigarettes,” Dr Konstantinos Farsalinos from the Onassis Cardiac Surgery Center in Athens told the annual meeting of the European Society of Cardiology.

“Considering the extreme hazards associated with cigarette smoking, currently available data suggest that electronic cigarettes are far less harmful and substituting tobacco with electronic cigarettes may be beneficial to health.”

Farsalinos and his team examined the heart function of 20 young smokers before and after smoking one tobacco cigarette against that of 22 e-cigarette users before and after using the device for seven minutes.

While the tobacco smokers suffered significant heart dysfunction, including raised blood pressure and heart rate, those using e-cigarettes had only a slight elevation in pressure.

The Greek clinical study was the first in the world to look at the cardiac effects of e-cigarettes. Another small study, also in Greece, reported earlier this year the devices had little impact on lung function.

Farsalinos acknowledged bigger studies were still needed to examine the possible long-term effects of e-cigarettes, while other doctors attending the medical meeting in Munich were cautious about giving them a clean bill of health just yet.

“Obviously, the e-cigarette has the advantage of not having the thousands of other chemicals, besides nicotine, that a real cigarette has,” said Dr Russell Luepker of the University of Minnesota.

“I don’t think it’s conclusive but there’s no doubt if you expose someone to fewer bioactive chemical compounds there is going to be less effect.”

E-cigarettes were first made in China in 2003 but are now sold around the world and used by millions of people.

(Reporting by Ben Hirschler; Editing by Andrew Heavens)

Are E-Cigs the Wave of the Future?

from http://www.cspnet.com/news/tobacco/articles/are-e-cigs-wave-future

NEW YORK — Use of electronic cigarettes could overtake consumption of traditional cigarettes within 10 years, Bonnie Herzog, New York City-based managing director of beverage, tobacco and consumer research for Wells Fargo Securities LLC, speculated in a research note.

“While difficult to predict, we think it is possible that consumption of e-cigarettes could outpace traditional cigarettes over the next decade, especially given the rapid pace of innovation and consumers’ demand for reduced harm products,” Herzog said.

She drew a parallel between e-cigs and energy drinks. “We think e-cigs are to tobacco what energy drinks are to the beverage industry; therefore, we think Big Tobacco needs to wake up and recognize the potential opportunity of the e-cigarette category and not make the mistakes of the large beverage companies that overlooked the potential of the energy drink category when it was in its nascent stage.”

Herzog’s bottom line: “We believe e-cigs are more than just a fad and most of our industry trade contacts agree. Considering both [Lorillard and Reynolds American] have dipped their toes in the e-cig waters, the next move is [Altria's], and we expect it to be big.”

In the spring, Lorillard Inc. acquired U.S. e-cigarette manufacturer blu ecigs for $135 million (see Related Content below for previous CSP Daily News coverage).

While the segment is currently small compared to the rest of the tobacco category–Lorillard estimates it generates about $300 million in revenue and the Tobacco Vapor Electronic Cigarette Association cites 2.5 million e-cig users–based on the responses to Wells Fargo’s “Tobacco Talk” surveys and a meeting with an e-cig leader, Herzog believes it won’t be long before electronic cigarettes represent a substantial portion of tobacco sales.

Retailers’ high level of enthusiasm is just one of the reasons Herzog believes e-cigarettes could surpass traditional cigarettes in upcoming years. When asked if e-cigarettes will become the new way to smoke, Tobacco Talk respondents offered many positive sentiments, including “as cigarettes decline in volume, e-cigarettes … will help pick up volume,” “it will eventually be the way to smoke since many areas are banning smoking in public areas” and “e-cigs are the new era of smoking.”

read more

510 T (Tank) eCig now available at EZ Smoke

The 510 T (Tank) eCigarette is now available to buy from Ireland’s Electronic Cigarette Supplier, EZ Smoke.ie

The NEW 510-T Starter Kit is the latest innovation which utilizes a “Tank” system to deliver the E-Liquid to the atomizer rather than Poly Filled Cartridges.

 

Some benefits to the 510-T Starter Kit are:

  • Less Refilling!
  • Great Vapour!
  • Small and Compact.
  • Sleek Design..

510-T atomizers are compatible with all 510 threaded e-cigs
Currently available in very fashionable Barbara Red, with more colours coming soon.

This 510-T is the perfect ecigarette for those who do not like the more bulky Ego type setup, and yet at the same time wish to experience the clean Tankomizer type system normally reserved for larger devices.

Read more at http://www.ezsmoke.ie/automatic-starter-berbara-p-186.html

RJ Reynolds to Launch eCig

In yet another sign that electronic cigarettes are becoming more mainstream, RJ Reynolds the second largest tobacco company in the USA and owners of Camel and Winston cigarette brands are launching their own disposable e-cig, called the ‘Vuse Solo’

 

Reynolds have said “We believe there is significant growth potential in these new product formats, and we believe that our expertise and proprietary technology will give us a competitive edge.”

I wonder which of the well known manufacturers this side of the pond will be first follow suit?